Solid Biosciences joins Jefferies Global Healthcare Conference with CEO Bo Cumbo fireside chat

Solid Biosciences joins Jefferies Global Healthcare Conference with CEO Bo Cumbo fireside chat
Solid Biosciences at Jefferies event

Solid Biosciences will participate in the Jefferies Global Healthcare Conference on June 3, where President and CEO Bo Cumbo is scheduled for a fireside chat at 7:35 AM ET.

The company announced that the session will be accessible via a live webcast. This engagement at one of the sector’s leading investor events underscores Solid Biosciences focus on genetic medicine and its continuing bid to communicate its vision to health care stakeholders.

Solid Biosciences recently presented insights into its SGT-003 gene therapy candidate for Duchenne muscular dystrophy at a leading scientific congress, according to a company update. Earlier in May, Chief Medical Officer Carl Morris discussed advances in targeted genetic therapy delivery at FierceBiotechWeek in Boston during a dedicated session. These appearances reinforce the company’s ongoing engagement at major industry events.

This material may contain third-party opinions, none of the data and information on this webpage constitutes investment advice according to our Disclaimer. While we adhere to strict Editorial Integrity, this post may contain references to products from our partners.
Weekly Top Bonuses
up to $2,500
deposit bonus for all clients
CLAIM BONUS
Your capital is at risk.